Pancreatic Cancer
What's New
Last Posted: Sep 22, 2022
- Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
Klink Andrew J et al. Targeted oncology 2022 - Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
NA Fraunhoffer et al, NPJ Precision Oncology, August 17, 2022 - Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review.
Chan Vivien Kin Yi et al. Frontiers in pharmacology 2022 13891149 - Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.
Everett Jessica N et al. Cancer medicine 2022 - Aberrant circulating tumour DNA methylations as biomarkers for early detection of pancreatic ductal adenocarcinoma: a retrospective study.
Guo Shiwei et al. The Lancet. Oncology 2022 23 Suppl 1S14 - Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.
Casolino Raffaella et al. Cancers 2022 14(13) - EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer.
Lehrer Steven et al. Cancer treatment and research communications 2022 32100595 - The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.
Walker Evan J et al. Pancreas 2022 - A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Salawu Abdulazeez et al. Targeted oncology 2022 - BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms.
Devico Marciano Naomie et al. Cancers 2022 14(10)
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
- NIH Information (5)
- COVID-19 (4)
- Human Genome Epidemiologic Studies (653)
- GWAS Studies (18)
- Human Genomics Translation/Implementation Studies (168)
- Genomic Tests Evidence Synthesis (21)
- Genomic Tests Guidelines (12)
- Tier-Classified Guidelines (5)
- Non-Genomics Precision Health (17)
- Pathogen Advanced Molecular Detection (3)
- State Public Health Genomics Programs (7)
- Reviews/Commentaries (143)
- Tools/Methods (2)
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Jul 25, 2022
- Page last updated:Sep 26, 2022
- Content source: